Telix Pharmaceuticals has partnered with Subtle Medical to integrate AI-powered SubtlePET™ software with its PSMA-PET product, Illuccix®. This collaboration aims to enhance PET imaging efficiency, reducing scan times by up to 75% while maintaining image quality, ultimately improving patient comfort and healthcare workflows. The partnership will initially launch in the U.S. and expand to other regions pending regulatory approval.
Telix Pharmaceuticals has partnered with Subtle Medical to integrate AI-driven SubtlePET™ software with its PSMA-PET product, Illuccix®. This collaboration aims to enhance PET imaging efficiency, achieving up to 75% time savings while maintaining image quality, ultimately improving patient comfort and healthcare workflows. The technology seamlessly fits into existing imaging processes, benefiting both medical facilities and patients, particularly in prostate cancer diagnostics.
Telix Pharmaceuticals has partnered with Subtle Medical to integrate AI-driven SubtlePET™ software with its PSMA-PET product, Illuccix®. This collaboration aims to enhance PET imaging efficiency, reducing scan times by up to 75% while maintaining image quality, ultimately improving patient care and operational workflows in medical facilities. The partnership will initially launch in the U.S. and expand to other regions pending regulatory approval.
Telix Pharmaceuticals has partnered with Subtle Medical to enhance PET imaging efficiency using AI-powered SubtlePET™ software with its PSMA-PET product, Illuccix®. This collaboration aims to reduce scan times by up to 75% without compromising image quality, improving patient comfort and operational workflows in medical facilities. The partnership will initially focus on the U.S. market, with plans to expand to other Telix PET tracers pending regulatory approval.
Telix Pharmaceuticals has partnered with Subtle Medical to enhance PET imaging efficiency using AI-powered SubtlePET™ software with its PSMA-PET product, Illuccix®. This collaboration aims to reduce scan times by up to 75%, improving patient comfort and optimizing healthcare workflows. The partnership will initially focus on the U.S. market, with plans to expand to other PET tracers pending regulatory approval.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
